Enfortumab Vedotin Biosimilar - Research Grade
Product Sizes
1mg
ICH5070V-1MG
5mg
ICH5070V-5MG
About this Product
- SKU:
- ICH5070V
- Additional Names:
- MMAE
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1mg/ml
- Extra Details:
- Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
- Immunogen:
- Nectin-4
- Isotype:
- IgG1
- Purity:
- >90% by SDS-PAGE
- Reactivities:
- Human
- Shipping Conditions:
- Ambient
- Storage Conditions:
- This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
- Supplier:
- ichorbio
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:enfortumab-vedotin-biosimilar-research-grade-ich5070v
